You are here

  • Home
  • Archive
  • Volume 8, Issue 1
  • Review: a single dose of nasal decongestant reduces congestion in the short term in adults with the common cold; insufficient evidence exists on the effectiveness of repeated doses

Article Text

Article menu
Download PDFPDF
Treatment
Review: a single dose of nasal decongestant reduces congestion in the short term in adults with the common cold; insufficient evidence exists on the effectiveness of repeated doses

https://doi.org/10.1136/ebn.8.1.12

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Taverner D, Latte J, Draper M. Nasal decongestants for the common cold. Cochrane Database Syst Rev 2004;(3):CD001953.

    Q Are nasal decongestants effective for reducing the symptom of nasal congestion in adults and children with the common cold? Are adverse effects associated with use?

    METHODS

    Embedded ImageData sources:

    Cochrane Central Register of Controlled Trials (Cochrane Library, Issue 1, 2004), Medline (1996 to February 2004), EMBASE/Excerpta Medica (1996 to February 2004), Current Contents (February 2004), hand searches of review citations from other references, and contact with known principal investigators and pharmaceutical companies.

    Embedded ImageStudy selection and assessment:

    randomised controlled trials (RCTs) in any language that compared topical or oral single active nasal decongestants (aqueous spray, drops or dry powder, tablets, or capsules) with placebo (>12 patients/group) in adults or children who had the common cold …

    View Full Text

    Footnotes

    • For correspondence: Dr D Taverner, Internal Medicine, Royal Adelaide Hospital, Adelaide, South Australia, Australia. dtavernemail.rah.sa.gov.au

    • Source of funding: Cochrane Acute Respiratory Infections Group, Australia.